Other preclinical studies have also applied Bifidobacterium bacteria in combination therapy with cytokines, such as granulocyte colony-stimulating factor (G-CSF), where increased anti-tumor effects have been observed [95]. The gene discussed is CSF3; the disease is neoplasm.